highperformr logo

4D Molecular Therapeutics's Overview

Total employees244
HeadquartersEmeryville
Founded2013

4D Molecular Therapeutics (4DMT) is a clinical-stage gene therapy company pioneering the development of next-generation, customized AAV vectors and product candidates. Utilizing its proprietary Therapeutic Vector Evolution platform, 4DMT aims to unlock the full potential of gene therapy for both rare and large market diseases by designing vectors that can be precisely targeted to specific tissues and overcome existing limitations of AAV technology. Their research focuses on ophthalmology, cardiology, and pulmonology, with a pipeline of innovative product candidates advancing through clinical trials. The company is committed to inventing and developing transformative genetic medicines to address unmet medical needs.

Where is 4D Molecular Therapeutics's Headquarters?

4D Molecular Therapeutics office4D Molecular Therapeutics office4D Molecular Therapeutics office4D Molecular Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the company's primary hub for executive leadership, corporate operations, research and development (R&D), process development, and quality control for its gene therapy candidates.

Notable Features:

Includes advanced research and development laboratories, process development labs, quality control facilities, and collaborative office spaces designed to foster innovation in gene therapy. The company also operates a nearby cGMP manufacturing facility.

Work Culture:

A dynamic, science-driven environment focused on innovation, collaboration, and a patient-centric approach. Emphasizes scientific rigor, teamwork, and a commitment to developing transformative genetic medicines in a fast-paced biotech setting.

HQ Significance:

Strategically located in the San Francisco Bay Area biotech hub, providing access to a rich talent pool, leading research institutions, and a vibrant ecosystem for life sciences. This location is central to 4DMT's mission of advancing its pipeline of targeted AAV gene therapies.

Values Reflected in HQ: The headquarters and associated facilities reflect the company's core values of innovation in genetic medicine, scientific excellence, and a commitment to patients, evident in its state-of-the-art infrastructure geared towards cutting-edge research, development, and manufacturing.

Location:

4D Molecular Therapeutics' core operations, including research, development, and manufacturing, are primarily centered in Emeryville, California, USA. While its physical operational footprint is U.S.-based, the company's impact is global. It conducts clinical trials that may involve international sites and aims to develop therapies for diseases affecting patient populations worldwide. Strategic collaborations and partnerships can also extend its reach and activities on an international scale.

Street Address:

5858 Horton Street, Suite 455

City:

Emeryville

State/Province:

California

Country:

USA

4D Molecular Therapeutics's Global Presence

Emeryville, California, USA

Address: An additional cGMP manufacturing facility in Emeryville, CA (separate from the main headquarters building).

Supports the company's R&D pipeline by providing in-house manufacturing capabilities for its AAV-based therapeutics. This ensures robust quality control and the ability to scale up production for clinical trials and eventual commercialization, leveraging the Bay Area's biotech infrastructure.

Buying Intent Signals for 4D Molecular Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of 4D Molecular Therapeutics

As of April 2025, 4D Molecular Therapeutics' leadership includes:

David Kirn, M.D. - Co-founder, Chief Executive Officer & President
Fred Kamal, Ph.D. - Chief Operating Officer & Chief Technical Officer
August Moretti - Chief Financial Officer
Robert Kim, M.D. - Chief Medical Officer
Scott Bizily - Chief Development Officer
Carolyn R. Slaymaker, Pharm.D. - Chief People & Corporate Operations Officer
John F. Indrieri - General Counsel & Corporate Secretary

Investors of 4D Molecular Therapeutics

4D Molecular Therapeutics has been backed by several prominent investors over the years, including:

Viking Global Investors LP
BlackRock Fund Advisors
The Vanguard Group, Inc.
State Street Global Advisors (SSgA)
Artisan Partners LP
Pfizer Ventures (early investor)
BVF Partners L.P. (early investor)
ArrowMark Partners (early investor)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

In the past 12 months, 4D Molecular Therapeutics has strengthened its leadership team with key appointments, including a new Chief Financial Officer and a new Chief Medical Officer, alongside an internal promotion to Chief Development Officer. No major C-suite departures were publicly announced during this period.

New Appointments:

August Moretti, August Moretti appointed as new Chief Financial Officer.
Robert Kim, M.D., Dr. Robert Kim appointed as new Chief Medical Officer.
Scott Bizily, Scott Bizily promoted to Chief Development Officer.

Technology (Tech Stack) used by 4D Molecular Therapeutics

Discover the tools 4D Molecular Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

4D Molecular Therapeutics Email Formats and Examples

Common email formats for 4D Molecular Therapeutics likely use the company's domain, 4dmt.com. Standard patterns include [first_initial][last] or [first].[last]. For example, an employee named Jane Doe might have an email address like jdoe@4dmt.com.

[first_initial][last]@4dmt.com

Format

jdoe@4dmt.com

Example

80%

Success rate

News and media

4DMT Press ReleaseFebruary 28, 2024

4D Molecular Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights

4DMT announced its financial results for Q4 and full year 2023, highlighting progress in its clinical programs, including 4D-150 for wet AMD and DME, and outlined upcoming milestones for its pipeline....more

4DMT Press ReleaseFebruary 8, 2024

4DMT Announces Positive Interim Data from Phase 2 PRISM Clinical Trial Demonstrating Robust Clinical Activity of 4D-150 in Patients with Wet Age-Related Macular Degeneration (Wet AMD)

4D Molecular Therapeutics shared encouraging interim results from the Phase 2 PRISM trial for its gene therapy candidate 4D-150, showing significant clinical activity and a favorable safety profile in patients with wet AMD, a leading cause of vision loss....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including 4D Molecular Therapeutics, are just a search away.